General anaesthesia in 12 pregnant ewes undergoing surgery for fetal physiological research was supplemented with an intravenous infusion of remifentanil. This allowed us to employ a lighter plane of surgical anaesthesia and to use intermittent positive pressure ventilation. Our aim was to improve fetomaternal outcome. We monitored maternal pulse, blood pressure, transcutaneous oxygen saturation and end-tidal carbon dioxide levels. Remifentanil doses of 0.75-2.0 g/kg/min were needed and typically this allowed halothane concentrations of 1-1.5% to be used for maintenance of anaesthesia. Surgery lasted up to 2.5 h. All 12 ewes and their singleton fetuses survived the peri-and postoperative period in good condition.
Anaesthesia for surgery on pregnant ewes may be associated with significant fetal and maternal morbidity and fetal mortality. This paper describes a refined anaesthetic technique resulting from collaboration between fetal physiology researchers and specialist anaesthetists with the aim of reducing this morbidity and mortality. The standard technique used in our laboratory had involved the use of spontaneous ventilation with a high inspired concentration of halothane in order to provide sufficient relaxation, analgesia and anaesthesia. Following surgery about 30% of fetuses were cardiovascularly compromised and unable to undergo the intended experimental study. We hypothesized that a technique involving an infusion of remifentanil, a new opioid with an extremely short duration of action (Egan 1995 (Egan , 2000 , would allow us to reduce the inspired concentration of halothane and also use intermittent positive pressure ventilation (IPPV) without neuromuscular blockade and thus improve fetomaternal outcomes. The metabolism of remifentanil depends on non-specific esterases in blood and tissues, so that even after prolonged infusions it is metabolized within minutes, and recovery from its effects is very rapid (Egan 1995) . It has been used previously in dogs (Chism & Rickert 1996 , Hoke et al. 1997 , pigs (Johnson et al. 2001) , horses (Lehner et al. 2000) and humans (Glass et al. 1993 , Egan 2000 , but not to our knowledge in sheep. Human studies during anaesthesia for Caesarean section indicate that remifentanil rapidly crosses the placen-tal barrier and achieves good concentrations in the fetus; also that it is rapidly metabolized by the fetus (Kan et al. 1998 ).
Materials and methods
The technique was used on 12 pregnant ewes undergoing fetal surgery for implantation of vascular catheters and peri-aortic flow meters (under Home Office Licence and approval by the Ethics Committee of Sutton Bonington Campus of the University of Nottingham). All pregnant ewes (Ovis ovis, Suffolk/Leicester cross) were of known gestational age (118-122 dGA, term 147) and weight. A singleton pregnancy was confirmed by ultrasound scanning. Food (hay, grass pellets) was withdrawn approximately 20 h before surgery. Ewes were given intramuscular (i.m.) multivitamins (Duphafral, Fort Dodge Animal Health Ltd, Southampton, UK; 5.0 ml: each 1 ml contains Vitamin A 15.000 IU, Vitamin D3 7.500 IU, Vitamin E 20 mg, Vitamin B1 10 mg, Vitamin B2 5 mg, Vitamin B6 3 mg, Nicotinamide 35 mg, D-Panthenol 25 mg, Vitamin B12 25 µg) and antibiotics (Depomycin Forte, Intervet UK, Walton, Milton Keynes, UK; 3.0 ml: Procaine Benzylpenicillin, 200 mg/ml and Dihydrostreptomycin 200 mg/ml) approximately 16 h prior to surgery. The ewes were weighed on the morning of surgery (range 50-60 kg).
One side of the neck was shaved and a 19 G butterfly needle was inserted into the external jugular vein. 10-15 mg/kg thiopentone sodium 2.5% (Intraval Sodium, Link Pharmaceutical Ltd, Horsham, West Sussex, UK) was injected to induce anaesthesia sufficient for laryngoscopy and tracheal intubation with a cuffed red rubber endotracheal tube (9.5-10 mm internal diameter) lubricated with aqueous 4% lignocaine gel. A Magill circuit was attached, spontaneous ventilation observed and anaesthesia initially maintained with halothane (Halothane, Concord Pharmaceuticals Ltd, Dunmow, Essex, UK) in oxygen. A 14 G cannula was inserted into the external jugular vein and secured, and the butterfly needle was removed. The ewe was transferred from the anaesthetic room into theatre and secured in dorsal recumbency with left lateral tilt on the operating table.
Monitors were then attached. They included electrocardiography (ECG) using needle electrodes, non-invasive blood pressure measurement using a human paediatric cuff applied over the proximal foreleg, pulse oximetry applied to the tongue, lip or shaved ear (whichever provided the best signal) and expired gas analysis for end-tidal carbon dioxide and halothane. Blood pressure and other physiological variables were recorded every 5 min. Our objectives were to maintain a systolic blood pressure greater than 70 mmHg with a heart rate between 60 and 100 bpm, and oxygen saturation on pulse oximetry of at least 95%. We aimed for fetal measurements of arterial partial pressure of oxygen (PaO 2 ) greater than 2.0 kPa. (we consider a fetal PaO 2 of 2.6 kPa or more as excellent, and less than 2.0 kPa as hypoxic). Pupil size and response, lacrimation, swallowing, shivering and crude assessment of neck muscle tone were used as clinical markers of depth of anaesthesia.
Remifentanil (Ultiva, Pharma International Ltd, Shannon, County Clare, Ireland) was reconstituted in normal saline to achieve a concentration of 100 g/ml. This was infused using a Treonic IP3 pump (Vicker's Medical, Basingstoke, Hampshire, UK) into the cannula in the external jugular vein. The initial infusion rate was set to 0.5 g/kg/min. This eliminated respiratory drive and allowed mechanical ventilation with a tidal volume of 10 ml/kg using a Manley ventilator. This is a minute volume divider, supplying the volume of gas set as the minute volume in equal sized breaths. Increasing the fresh gas flow with this ventilator increases the minute volume given, i.e. the rate of mechanical ventilation. The initial oxygen flow rate was 5-6 l/min. Airway pressures were kept between 20-25 mmHg. Oxygen flow rate was adjusted to achieve an expired end-tidal carbon dioxide concentration of approximately 4.5 kPa and the inspired halothane concentration was titrated to achieve an adequate but light plane of anaesthesia (maintenance rates 0.5-1.5%).
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Antiseptic preparation of the operative field and arranging of sterile drapes were done whilst the remifentanil infusion was being set up. Once this had been done, mechanical ventilation commenced and then the surgeon proceeded with the laparotomy. In contrast to our experience in humans, the infusion rate of remifentanil sometimes had to be increased as surgery progressed in order to satisfactorily abolish lacrimation and swallowing. The maximum infusion rate required was 2 g/kg/min but we rarely needed to go this high (and this is about twice the maximum rate that we have used in humans). Generally we used a little over one milligram per 10 kg body weight for a 2 h surgery.
Changes in the remifentanil infusion rate were all in response to clinical evidence of insufficient depth of anaesthesia or analgesia (swallowing/shivering). Between 500 and 1000 ml of Hartmann's solution was infused during surgery for maintenance fluid requirements and to replace surgical losses. This was usually followed by 500-1000 ml of a gelatin-based colloid (gelofusin). Blood loss was minimal in all operations, but there was sometimes considerable loss of amniotic fluid after hysterotomy, whilst the fetus was being manipulated. Fluid losses were also apparent due to saliva production and from exposed viscera. Blood pressures were well maintained, suggesting the fluid replacement was adequate (see Fig 1) .
Finadyne 2.0 ml (50 mg/ml Flunixin Meglumine), a potent non-steroidal antiinflammatory drug, was given i.m. towards the end of surgery to provide postoperative analgesia along with a second dose of depomycin forte i.m. and 500 mg of intraamniotic (i.a.) ampicillin (given via an i.a. catheter).
As surgery neared completion the remifentanil infusion rate was reduced, and upon insertion of the last skin clips both the remifentanil infusion and halothane were stopped. On resumption of spontaneous ventilation the endotracheal tube was removed and the ewe returned to a recovery pen. On the day following surgery a further dose of Finadyne 1.5-2.0 ml i.m., Depomycin Forte 3.0 ml i.m. and ampicillin 500 mg i.a. were given to the ewes. After this they were only given further analgesia if they appeared to need it.
The ewes were euthanized 8-15 days postsurgery by intravenous administration of an overdose of pentobarbitone 20% ('euthatal'). The ewes were given a 30 ml bolus and 5 ml was also given to the fetus through one of its i.v. catheters.
Results
All 12 ewes and their singleton fetuses survived the peri-and postoperative period in good condition. The technique provided very stable haemodynamic conditions and no subjects required any pharmacological or fluid support for pulse or blood pressure. At no stage did we observe excessive bradycardia, hypotension or chest wall muscle rigidity that are the usual indicators of excessive opiod dose. Resumption of spontaneous ventilation was generally within 2-4 min. No animals displayed evidence of excessive pain or distress in the immediate postoperative period. All ewes were standing within an hour (often by 30 min, one by 10 min) and all resumed eating, drinking and defaecating in the few hours following surgery. This is in stark contrast to previous surgeries following which ewes were slow to stand up and start eating and drinking.
All subjects remained in good condition, except one ewe in which evidence of sepsis was found at post-mortem. This must have developed later as she was in excellent condition until 24 h before she went into early labour, 10 days after surgery. We suspect she developed peritonitis from infection at her trochar site, where the catheters pass through the flank.
Prior to being euthanized, one ewe had delivered (as above) and another was showing signs of starting labour (at 139 days gestation). Our experience is that ewes who have undergone fetal surgery generally labour a few days before the expected term (147 days gestation). All the others had reached the end of the experiments. Fetal measurements of arterial partial pressure of oxygen (PaO 2 ) were variable at this time (2.0-3.0 kPa). 
Discussion
We have demonstrated improved outcome in pregnant ewes undergoing fetal surgery by employing an anaesthetic technique that includes a remifentanil infusion. We believe that these good results are, in part, due to the more favourable intraoperative and postoperative physiological conditions provided by the use of remifentanil. We also believe that the sheep benefited from other improvements in anaesthetic technique. These include closer intraoperative monitoring and record keeping, adequate fluid replacement, use of the minimum necessary doses of inhalant anaesthetics (which have adverse cardiovascular effects in high doses), intermittent positive pressure ventilation and careful surgical positioning to avoid aorto-caval compression.
Remifentanil is a potent, selective -opioid receptor agonist, structurally related to fentanyl, developed for use in anaesthesia. It provides profound analgesia (20-30 times greater than alfentanil in humans (Glass et al. 1993 ) and up to 8.5 times more potent than alfentanil in dogs (Hoke et al. 1997) ). Its unique characteristic of rapid and predictable times of onset and recovery makes it an opioid that is easily titrated to the surgical stimulus. It is suitable for either short surgeries in which profound analgesia is required, or for longer surgeries as an infusion without the concern of a prolonged recovery. It is metabolized by non-specific tissue and plasma esterases to virtually inactive metabolites. Its half-life in humans is 3-10 min, independent of the infusion duration (Westmoreland et al. 1993) . At a sufficient dose it abolishes the respiratory drive and more easily allows mechanical ventilation of the lungs without neuromuscular blocking agents, high concentrations of inspired halothane or hypercapnia. There are few data in the literature on its use in sheep though it has been extensively researched in animal studies and is now widely used in human anaesthetic practice. Remifentanil has been shown to cross the human placenta but appears to be rapidly metabolized, redistri-buted, or both without adverse neonatal or maternal effects (Kan et al. 1998) .
Good physiological conditions were achieved with this anaesthetic protocol. Blood pressure is maintained close to normal, there is a reduced risk of dysrhythmias, and more profound analgesia reduces the endocrine stress response to surgery. Respiratory acidosis, an inevitable consequence of spontaneous ventilation during general anaesthesia, especially in pregnant sheep in dorsal recumbency, is avoided by using mechanical ventilation. Ewes are better oxygenated because they are mechanically ventilated. Maintenance of a normal blood pressure and acid-base status optimizes the blood flow to the fetoplacental unit and increases the chance of a good fetal outcome. A more rapid maternal and fetal recovery from anaesthesia is achieved by a reduction in the required concentration of halothane and the rapid offset time of remifentanil. Remifentanil is not devoid of cardiovascular side effects. Although it does not cause histamine release, it can produce bradycardia and hypotension by its central vagotonic effect and by stimulating peripheral -opioid receptors. However these effects appear to be counteracted and masked by its central sympathomimetic effect and by its maintainance of arterial baroreflex integrity (Shinohara et al. 2000) .
The rapid offset of remifentanil avoids the dangers of respiratory depression, hypercapnia and acidosis extending into the postoperative period, which can complicate the use of longer-acting opioids. A less desirable consequence of the rapid offset is the loss of analgesia on cessation of infusion. Supplementary analgesics must be in place before remifentanil is stopped. We chose to use long-acting non-steroidal analgesics rather than opiates for postoperative analgesia, with good effect. Non-steroidal analgesics cause less nausea in humans than opiates; this may also be true in sheep and may provide another reason why our ewes returned to normal eating and drinking patterns soon after surgery.
The cost of remifentanil is calculated at around £32.00 per sheep, based on the average use of 6 mg per sheep. This additional cost is partially offset by the reduction in use of halothane.
Conclusion
We believe that the use of remifentanil in our anaesthetic technique has improved the condition of ewe and fetus both intraoperatively and postoperatively. We also believe that the specialist anaesthetists who have implemented the use of this novel drug in our practice have also influenced us towards closer intraoperative vigilance with regard to maintaining normocapnia, fluid administration, monitoring and record keeping-all to the animals' benefit.
